Upregulation of angiostatic chemokines IP-10/CXCL10 and I-TAC/CXCL11 in human obesity and their implication for adipose tissue angiogenesis

被引：0
|
作者：
Luisa Hueso
Rebeca Ortega
Francisca Selles
Ning Yun Wu-Xiong
Joaquin Ortega
Miguel Civera
Juan F Ascaso
Maria-Jesus Sanz
José T Real
Laura Piqueras
机构：
[1] Institute of Health Research-INCLIVA,Department of Pharmacology, Faculty of Medicine
[2] University of Valencia,Endocrinology and Nutrition Service
[3] University Clinic Hospital of Valencia,Surgery Service
[4] University Clinic Hospital of Valencia,Department of Surgery
[5] University of Valencia,undefined
[6] CIBERDEM: Diabetes and Associated Metabolic Diseases Networking Biomedical Research- ISCIII,undefined
来源：
International Journal of Obesity | 2018年 / 42卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1406 / 1417
页数：11
相关论文
共 50 条
  • [21] Citrullination of CXCL10 and CXCL11 by peptidylarginine deiminase: a naturally occurring posttranslational modification of chemokines and new dimension of immunoregulation
    Loos, Tamara
    Mortier, Anneleen
    Gouwy, Mieke
    Ronsse, Isabelle
    Put, Willy
    Lenaerts, Jean-Pierre
    Van Damme, Jo
    Proost, Paul
    BLOOD, 2008, 112 (07) : 2648 - 2656
  • [22] The chemokines IP-10/CXCL10 and IL-8/CXCL8 are potential novel biomarkers of warm autoimmune hemolytic anemia
    Branch, Donald R.
    Leger, Regina M.
    Sakac, Darinka
    Yi, Qilong
    Duong, Trang
    Yeung, Rae S. M.
    Binnington, Beth
    Bloch, Evgenia M.
    BLOOD ADVANCES, 2023, 7 (10) : 2166 - 2170
  • [23] Differential expression of CXCR3 targeting chemokines CXCL10, CXCL9, and CXCL11 in different types of skin inflammation
    Flier, J
    Boorsma, DM
    van Beek, PJ
    Nieboer, C
    Stoof, TJ
    Willemze, R
    Tensen, CP
    JOURNAL OF PATHOLOGY, 2001, 194 (04): : 398 - 405
  • [24] Expression and regulation of interferon-γ inducible protein 10 (IP-10/CXCL10) in human adipocytes
    Skurk, T
    Herder, C
    Kolb, H
    Hauner, H
    INTERNATIONAL JOURNAL OF OBESITY, 2005, 29 : S5 - S5
  • [25] Evaluation of CXCL10, CXCL11, CXCL12 and CXCL13 chemokines in serum and cerebrospinal fluid in patients with tick borne encephalitis (TBE)
    Zajkowska, J.
    Moniuszko-Malinowska, A.
    Pancewicz, S. A.
    Muszynska-Mazur, A.
    Kondrusik, M.
    Grygorczuk, S.
    Swierzbinska-Pijanowska, R.
    Dunaj, J.
    Czupryna, P.
    ADVANCES IN MEDICAL SCIENCES, 2011, 56 (02): : 311 - 317
  • [26] Oncolytic reovirus inhibits angiogenesis through induction of CXCL10/IP-10 and abrogation of HIF activity in soft tissue sarcomas
    Carew, Jennifer S.
    Espitia, Claudia M.
    Zhao, Weiguo
    Mita, Monica M.
    Mita, Alain C.
    Nawrocki, Steffan T.
    ONCOTARGET, 2017, 8 (49) : 86769 - 86783
  • [27] Improvement of CXCR3 ligand CXCL11/I-TAC measurement in human plasma and serum
    Cremasco, Viviana
    Mantelli, Barbara
    Lazzarin, Adriano
    Biswas, Priscilla
    NEW MICROBIOLOGICA, 2009, 32 (01): : 125 - 128
  • [28] Effect of JAK Inhibitors on Release of CXCL9, CXCL10 and CXCL11 from Human Airway Epithelial Cells
    Fenwick, Peter S.
    Macedo, Patricia
    Kilty, Iain C.
    Barnes, Peter J.
    Donnelly, Louise E.
    PLOS ONE, 2015, 10 (06):
  • [29] CCL5, CXCL10 and CXCL11 Chemokines in Patients with Active and Stable Relapsing-Remitting Multiple Sclerosis
    Szczucinski, Adam
    Losy, Jacek
    NEUROIMMUNOMODULATION, 2011, 18 (01) : 67 - 72
  • [30] Differential expression of CXC chemokines CXCL10 (IP-10) and CXCL12 (SDF-1α) in term and pre-term neonates
    Saeedeh, Nabati
    Mahmoodi, Mehdi
    Aminzadeh, Fariba
    Hassanshahi, Gholamhossein
    CLINICAL BIOCHEMISTRY, 2011, 44 (13) : S271 - S272
12345